NOVEL METHOD FOR QUANTIFYING HEPATIC STEATOSIS IN PATIENTS WITH METABOLICALLY ASSOCIATED FATTY LIVER DISEASE

Introduction. The article presents an overview of novel complex algorithm based on methods ultrasound steatometry, combined elastography and dual-energy X-ray absorbtiometry in “Whole body” mode diagnostic monitoring metabolically associated fatty liver disease. purpose the study: to assess possibility quantitative steatometry using detection Material methods. 157 patients were examined. main group consisted 47 with steatosis; 45 steatohepatitis clinically insignificant fibrosis (F0-F1); 32 significant (F2-F3); 33 focal hepatic steatosis. We used questionnaires, laboratory tests, x-ray mode, biopsy. determine severity steatosis, a scale was used: S0 – no 2.9 dB/cm. Results conclusion. It is possible use for disease, as reference method both initial disease non-drug treatment (sensitivity 90.7%, specificity 92.4%). optimal diagnosis includes assessment level compliance, absorptiometry «Whole body» 92.8%, 92.3%).